Cargando…
Response to Comment to the Article “Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?” [Response To Letter]
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790139/ https://www.ncbi.nlm.nih.gov/pubmed/36575680 http://dx.doi.org/10.2147/DMSO.S400278 |
| _version_ | 1784859107771023360 |
|---|---|
| author | Dzięgielewska-Gęsiak, Sylwia Fatyga, Edyta Piłot, Magdalena Wierzgoń, Aleksander Muc-Wierzgoń, Małgorzata |
| author_facet | Dzięgielewska-Gęsiak, Sylwia Fatyga, Edyta Piłot, Magdalena Wierzgoń, Aleksander Muc-Wierzgoń, Małgorzata |
| author_sort | Dzięgielewska-Gęsiak, Sylwia |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9790139 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Dove |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97901392022-12-26 Response to Comment to the Article “Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?” [Response To Letter] Dzięgielewska-Gęsiak, Sylwia Fatyga, Edyta Piłot, Magdalena Wierzgoń, Aleksander Muc-Wierzgoń, Małgorzata Diabetes Metab Syndr Obes Response to Letter Dove 2022-12-21 /pmc/articles/PMC9790139/ /pubmed/36575680 http://dx.doi.org/10.2147/DMSO.S400278 Text en © 2022 Dzięgielewska-Gęsiak et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
| spellingShingle | Response to Letter Dzięgielewska-Gęsiak, Sylwia Fatyga, Edyta Piłot, Magdalena Wierzgoń, Aleksander Muc-Wierzgoń, Małgorzata Response to Comment to the Article “Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?” [Response To Letter] |
| title | Response to Comment to the Article “Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?” [Response To Letter] |
| title_full | Response to Comment to the Article “Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?” [Response To Letter] |
| title_fullStr | Response to Comment to the Article “Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?” [Response To Letter] |
| title_full_unstemmed | Response to Comment to the Article “Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?” [Response To Letter] |
| title_short | Response to Comment to the Article “Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?” [Response To Letter] |
| title_sort | response to comment to the article “are there differences in gut microbiome in patients with type 2 diabetes treated by metformin or metformin and insulin?” [response to letter] |
| topic | Response to Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790139/ https://www.ncbi.nlm.nih.gov/pubmed/36575680 http://dx.doi.org/10.2147/DMSO.S400278 |
| work_keys_str_mv | AT dziegielewskagesiaksylwia responsetocommenttothearticlearetheredifferencesingutmicrobiomeinpatientswithtype2diabetestreatedbymetforminormetforminandinsulinresponsetoletter AT fatygaedyta responsetocommenttothearticlearetheredifferencesingutmicrobiomeinpatientswithtype2diabetestreatedbymetforminormetforminandinsulinresponsetoletter AT piłotmagdalena responsetocommenttothearticlearetheredifferencesingutmicrobiomeinpatientswithtype2diabetestreatedbymetforminormetforminandinsulinresponsetoletter AT wierzgonaleksander responsetocommenttothearticlearetheredifferencesingutmicrobiomeinpatientswithtype2diabetestreatedbymetforminormetforminandinsulinresponsetoletter AT mucwierzgonmałgorzata responsetocommenttothearticlearetheredifferencesingutmicrobiomeinpatientswithtype2diabetestreatedbymetforminormetforminandinsulinresponsetoletter |